Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc.Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪34.75 M‬USD
−1.3068USD
‪−20.06 M‬USD
‪1.08 M‬USD
‪15.96 M‬
Beta (1Y)
−0.97

About Cyclo Therapeutics, Inc.

CEO
Nathan Scott Fine
Headquarters
Gainesville
Employees (FY)
8
Founded
1990
FIGI
BBG00YGCSYC3
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.